Hamilton Lane (NASDAQ:HLNE - Get Free Report) had its target price raised by research analysts at Wells Fargo & Company from $103.00 to $114.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has an "overweight" rating on the stock. Wells Fargo & Company's price target suggests a potential upside of 24.44% from the stock's current price.
Several other research analysts have also issued reports on the company. Morgan Stanley set a $118.00 target price on Hamilton Lane in a research report on Friday, October 16th. The Goldman Sachs Group reaffirmed a "buy" rating and set a $117.00 price target on shares of Hamilton Lane in a research note on Friday, October 2nd. UBS Group reduced their price objective on shares of Hamilton Lane from $131.00 to $115.00 and set a "buy" rating for the company in a report on Tuesday, October 13th. Weiss Ratings upgraded Hamilton Lane from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, August 31st. Finally, Oppenheimer dropped their target price on shares of Hamilton Lane from $182.00 to $181.00 and set an "outperform" rating on the stock in a research report on Thursday, August 27th. Seven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, Hamilton Lane presently has an average rating of "Moderate Buy" and an average price target of $126.00.
Read Our Latest Analysis on Hamilton Lane
Hamilton Lane Price Performance
Shares of Hamilton Lane stock traded up $2.98 during midday trading on Wednesday, hitting $91.61. 68,799 shares of the company traded hands, compared to its average volume of 766,565. Hamilton Lane has a 12 month low of $71.88 and a 12 month high of $155.66. The company has a debt-to-equity ratio of 0.16, a quick ratio of 3.49 and a current ratio of 3.49. The stock has a market cap of $5.09 billion, a price-to-earnings ratio of 13.99 and a beta of 1.16. The firm's fifty day moving average price is $90.30 and its 200-day moving average price is $97.50.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.33. Hamilton Lane had a net margin of 32.14% and a return on equity of 25.10%. The company had revenue of $204.43 million during the quarter, compared to the consensus estimate of $215.23 million. During the same period in the prior year, the business earned $1.54 earnings per share. The company's revenue for the quarter was up 7.1% compared to the same quarter last year. As a group, sell-side analysts forecast that Hamilton Lane will post 7.47 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. Public Employees Retirement System of Ohio lifted its holdings in Hamilton Lane by 0.3% during the 1st quarter. Public Employees Retirement System of Ohio now owns 44,678 shares of the company's stock worth $4,441,000 after purchasing an additional 115 shares in the last quarter. Empowered Funds LLC boosted its stake in Hamilton Lane by 0.6% in the 1st quarter. Empowered Funds LLC now owns 21,114 shares of the company's stock worth $2,099,000 after purchasing an additional 122 shares during the period. Gibbs Wealth Management grew its holdings in Hamilton Lane by 3.0% during the 3rd quarter. Gibbs Wealth Management now owns 4,532 shares of the company's stock valued at $394,000 after buying an additional 132 shares in the last quarter. Crossmark Global Holdings Inc. grew its holdings in Hamilton Lane by 9.4% during the 3rd quarter. Crossmark Global Holdings Inc. now owns 2,995 shares of the company's stock valued at $260,000 after buying an additional 258 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund grew its holdings in Hamilton Lane by 3.4% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 8,400 shares of the company's stock valued at $835,000 after buying an additional 276 shares in the last quarter. Institutional investors own 97.40% of the company's stock.
More Hamilton Lane News
Here are the key news stories impacting Hamilton Lane this week:
- Positive Sentiment: Fiscal Q2 adjusted earnings were $1.98 per share, topping consensus estimates and rising from $1.54 a year earlier. Fee-related earnings reportedly surged 34%, with the fee margin reaching 51%. Hamilton Lane Q2 earnings
- Positive Sentiment: Total assets grew 7% year over year to $1.1 trillion, while evergreen platform AUM climbed 42% to nearly $21 billion, pointing to continued scale and growth in a key platform. Three key takeaways for long-term investors
- Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $120 from $116 and maintained an Outperform rating. Hamilton Lane also announced a quarterly dividend of $0.60 per share, equivalent to $2.40 annualized, extending its dividend-growth streak to nine years. Keefe, Bruyette & Woods rating Dividend increase analysis
- Neutral Sentiment: A new partnership with FactSet aims to provide integrated private-markets analytics. It could broaden Hamilton Lane’s reach, though the reports did not specify an expected near-term financial contribution. FactSet partnership announcement
- Negative Sentiment: Quarterly revenue of $204.43 million was below the roughly $215 million analyst consensus, despite growing 7.1% year over year. Commentary about uneven growth and questions about dividend durability amid a difficult private-markets environment remain risks. Revenue missed estimates
Hamilton Lane Company Profile
(
Get Free Report)
Hamilton Lane Incorporated NASDAQ: HLNE is a global investment management firm specializing in private markets. The company provides investment solutions and advisory services focused on alternative assets, including private equity, private credit, venture capital, growth equity, infrastructure and real assets.
Hamilton Lane serves institutional investors, family offices, financial advisors and high-net-worth individuals. Its offerings include separately managed accounts, customized portfolios, commingled funds, evergreen vehicles and secondary-market strategies.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.